Aquestive Therapeutics, Inc. 10-Q filing
Filed 2025-11-05 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001398733-25-000028
- Form type
- 10-Q
- CIK
- 0001398733
- Primary document
- https://www.sec.gov/Archives/edgar/data/1398733/000139873325000028/aqst-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aquestive Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $31.5M | - | - |
| Cost Of Revenue | $12.7M | - | - |
| Operating Income | $-42.2M | - | - |
| Net Income | $-51.9M | - | - |
| Eps Basic | -0.51 | - | - |
| Eps Diluted | -0.51 | - | - |
| Cash And Equivalents | $129.1M | - | - |
| Total Assets | $163.6M | - | - |
| Total Liabilities | $167.7M | - | - |
| Shareholders Equity | $-4.1M | - | - |
| Operating Cash Flow | $-44.0M | - | - |
| Capital Expenditures | $477,000 | - | - |